The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Sydney, NSW, Australia.
School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Br J Cancer. 2022 Jul;127(1):116-125. doi: 10.1038/s41416-022-01790-x. Epub 2022 Mar 28.
We examined whether digital breast tomosynthesis (DBT) detects differentially in high- or low-density screens.
We searched six databases (2009-2020) for studies comparing DBT and digital mammography (DM), and reporting cancer detection rate (CDR) and/or recall rate by breast density. Meta-analysis was performed to pool incremental CDR and recall rate for DBT (versus DM) for high- and low-density (dichotomised based on BI-RADS) and within-study differences in incremental estimates between high- and low-density. Screening settings (European/US) were compared.
Pooled within-study difference in incremental CDR for high- versus low-density was 1.0/1000 screens (95% CI: 0.3, 1.6; p = 0.003). Estimates were not significantly different in US (0.6/1000; 95% CI: 0.0, 1.3; p = 0.05) and European (1.9/1000; 95% CI: 0.3, 3.5; p = 0.02) settings (p for subgroup difference = 0.15). For incremental recall rate, within-study differences between density subgroups differed by setting (p < 0.001). Pooled incremental recall was less in high- versus low-density screens (-0.9%; 95% CI: -1.4%, -0.4%; p < 0.001) in US screening, and greater (0.8%; 95% CI: 0.3%, 1.3%; p = 0.001) in European screening.
DBT has differential incremental cancer detection and recall by breast density. Although incremental CDR is greater in high-density, a substantial proportion of additional cancers is likely to be detected in low-density screens. Our findings may assist screening programmes considering DBT for density-tailored screening.
我们研究了数字乳腺断层摄影术(DBT)在高低密度屏幕上的检测是否存在差异。
我们在六个数据库(2009 年至 2020 年)中搜索了比较 DBT 和数字乳腺摄影术(DM)的研究,并报告了按乳腺密度分类的癌症检出率(CDR)和/或召回率。采用荟萃分析对 DBT(与 DM 相比)的增量 CDR 和召回率进行汇总,以高、低密度(根据 BI-RADS 二分类),以及高、低密度之间增量估计值的研究内差异。比较了筛查环境(欧洲/美国)。
高、低密度之间的增量 CDR 研究内差异为 1.0/1000 例(95%置信区间:0.3,1.6;p=0.003)。美国(0.6/1000;95%置信区间:0.0,1.3;p=0.05)和欧洲(1.9/1000;95%置信区间:0.3,3.5;p=0.02)的估计值没有显著差异(组间差异的 p 值=0.15)。对于增量召回率,密度亚组之间的研究内差异因环境而异(p<0.001)。在美国筛查中,高、低密度屏幕之间的增量召回率差异有统计学意义(-0.9%;95%置信区间:-1.4%,-0.4%;p<0.001),而在欧洲筛查中则较高(0.8%;95%置信区间:0.3%,1.3%;p=0.001)。
DBT 对乳腺密度的增量癌症检测和召回率存在差异。尽管高密度时的增量 CDR 较高,但在低密度屏幕中可能会检测到更多的额外癌症。我们的研究结果可能有助于考虑为密度定制筛查的筛查项目。